Julie Jordan's Net Worth
$2.71 Thousand
Who is Julie Jordan?
Julie Jordan does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Homology Medicines, Inc., and Neurogene Inc..
SEC CIK
Julie Jordan's CIK is 0001968554
Past Insider Trading and Trends
2023 was Julie Jordan's most active year for acquiring shares with 4 total transactions. Julie Jordan's most active month to acquire stocks was the month of July. 2023 was Julie Jordan's most active year for disposing of shares, totalling 8 transactions. Julie Jordan's most active month to dispose stocks was the month of July. 2024 saw Julie Jordan paying a total of $0.00 for 75,000 shares, this is the most they've acquired in one year. In 2023 Julie Jordan cashed out on 8,881 shares for a total of $2,705.36, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Homology Medicines, Inc. (FIXX) No price found
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +170.61% | 4.73K |
$1.39 | -$2,575.67 | 7.5K |
Aug 3
| |||
Form 4
| +9.96% | 251 |
$1.31 | -$129.69 | 2.77K |
Aug 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Neurogene Inc. (NLTX) No price found
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |